Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ioannidis, J. P.A.
Right arrow Articles by Lau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ioannidis, J. P.A.
Right arrow Articles by Lau, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 677-689
© 2001 The British Society for Antimicrobial Chemotherapy

Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections

John P. A. Ioannidisa,b, Despina G. Contopoulos-Ioannidisa,c, Priscilla Chewb and Joseph Laub,*

a Clinical Trials and Evidence-Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece; b Division of Clinical Care Research, New England Medical Center, Department of Medicine, Tufts University School of Medicine, 750 Washington Street, Box 63, Boston, MA 02111; c Department of Pediatrics, George Washington University School of Medicine, Washington, DC 20010, USA

We carried out a meta-analysis of randomized controlled trials comparing 3–5 days of azithromycin with other antibiotics that are typically given in longer courses for the treatment of upper respiratory tract infections. For acute otitis media (19 comparisons including 3421 patients), acute sinusitis (11 comparisons including 1742 patients) and acute pharyngitis (16 comparisons including 2447 patients), azithromycin had similar clinical failure rates to the other antibiotics [random effects odds ratios 1.12, 95% confidence interval (CI) 0.81–1.54; 0.91, 95% CI 0.60–1.39; and 1.07, 95% CI 0.59–1.94, respectively]. The difference in clinical failures was <0.5%, and no 95% CIs exceeded 2.0%. There was no heterogeneity between studies. Subtle differences between comparators could have been due to chance. There were no significant differences in bacteriological outcomes. Azithromycin was discontinued because of adverse events in only 37 of 4870 (0.8%) patients. Short courses of azithromycin are as effective as longer courses of other antibiotics for upper respiratory tract infections. Convenience of dosing should be balanced against the increased cost of this regimen for the treatment of these common infections, where often no antibiotic may be indicated at all.

* Corresponding author. Tel: +1-617-636-7670; Fax: +1-617-636-8023; E-mail: JLaul{at}lifespan.org


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. W. Dunne, T. Latiolais, B. Lewis, B. Pistorius, G. Bottenfield, W. H. Moore, A. Garrett, T. D. Stewart, J. Aoki, C. Spiegel, et al.
Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media
J. Antimicrob. Chemother., September 1, 2003; 52(3): 469 - 472.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. A. Steinman, R. Gonzales, J. A. Linder, and C. S. Landefeld
Changing Use of Antibiotics in Community-Based Outpatient Practice, 1991-1999
Ann Intern Med, April 1, 2003; 138(7): 525 - 533.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. A. Steinman, C. S. Landefeld, and R. Gonzales
Predictors of Broad-Spectrum Antibiotic Prescribing for Acute Respiratory Tract Infections in Adult Primary Care
JAMA, February 12, 2003; 289(6): 719 - 725.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. G. Contopoulos-Ioannidis, J. P. A. Ioannidis, P. Chew, and J. Lau
Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections
J. Antimicrob. Chemother., November 1, 2001; 48(5): 691 - 703.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.